News
A new report looks at hiring trends © 2025 American City Business Journals. All rights reserved. Use of and/or registration ...
15h
Zacks Investment Research on MSNFDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV PillMerck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...
The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public ...
It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...
A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.
"EQUIP-A-Pharma is about point-of-need manufacturing—hospitals, military bases, disaster zones—ensuring rapid drug ...
The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.
Here’s how a drug gets from an idea into patients’ hands – and why Australians sometimes wait longer to access a new drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results